Risk of New-Onset Type 2 Diabetes Among Vaccinated Adults After Omicron or Delta Variant SARS-CoV-2 Infection
- PMID: 40172892
- PMCID: PMC11966305
- DOI: 10.1001/jamanetworkopen.2025.2959
Risk of New-Onset Type 2 Diabetes Among Vaccinated Adults After Omicron or Delta Variant SARS-CoV-2 Infection
Plain language summary
This cohort study estimates the risk of new-onset type 2 diabetes after Delta or Omicron variant SARS-CoV-2 infection among vaccinated adults in Singapore.
Conflict of interest statement
References
-
- Taylor K, Eastwood S, Walker V, et al. ; Longitudinal Health and Wellbeing and Data and Connectivity UK COVID-19 National Core Studies; CONVALESCENCE study; OpenSAFELY collaborative . Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people. Lancet Diabetes Endocrinol. 2024;12(8):558-568. doi:10.1016/S2213-8587(24)00159-1 - DOI - PMC - PubMed
-
- Wee LE, Pang D, Chiew C, et al. . Long-term real-world protection afforded by third mRNA doses against symptomatic severe acute respiratory syndrome coronavirus 2 infections, coronavirus disease 19-related emergency attendances and hospitalizations amongst older Singaporeans during an Omicron XBB wave. Clin Infect Dis. 2023;77(8):1111-1119. doi:10.1093/cid/ciad345 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
